293 related articles for article (PubMed ID: 12085102)
1. Bone mineral density in hypogonadal men remains low after long-term testosterone replacement.
Ishizaka K; Suzuki M; Kageyama Y; Kihara K; Yoshida K
Asian J Androl; 2002 Jun; 4(2):117-21. PubMed ID: 12085102
[TBL] [Abstract][Full Text] [Related]
2. [Effect of immunosuppression-induced hypogonadism on bone metabolism after heart transplantation].
Stief J; Sohn HY; Alt A; Uberfuhr P; Theisen K; Stempfle HU
Dtsch Med Wochenschr; 2004 Jul; 129(31-32):1674-8. PubMed ID: 15273918
[TBL] [Abstract][Full Text] [Related]
3. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men.
Behre HM; Kliesch S; Leifke E; Link TM; Nieschlag E
J Clin Endocrinol Metab; 1997 Aug; 82(8):2386-90. PubMed ID: 9253305
[TBL] [Abstract][Full Text] [Related]
4. Effects of long-term testosterone substitutive therapy on bone mineral content in men with hypergonadotrophic hypogonadism.
Medras M; Jankowska EA; Rogucka E
Andrologia; 2001 Jan; 33(1):47-52. PubMed ID: 11167519
[TBL] [Abstract][Full Text] [Related]
5. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.
Katznelson L; Finkelstein JS; Schoenfeld DA; Rosenthal DI; Anderson EJ; Klibanski A
J Clin Endocrinol Metab; 1996 Dec; 81(12):4358-65. PubMed ID: 8954042
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study.
Aversa A; Bruzziches R; Francomano D; Greco EA; Fornari R; Di Luigi L; Lenzi A; Migliaccio S
Aging Male; 2012 Jun; 15(2):96-102. PubMed ID: 22439807
[TBL] [Abstract][Full Text] [Related]
7. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.
Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ
J Androl; 1998; 19(6):761-8. PubMed ID: 9876028
[TBL] [Abstract][Full Text] [Related]
8. Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis.
Diamond T; Stiel D; Posen S
J Bone Miner Res; 1991 Jan; 6(1):39-43. PubMed ID: 2048430
[TBL] [Abstract][Full Text] [Related]
9. The clinical significance of bone mineral density and testosterone levels in Korean men with non-mosaic Klinefelter's syndrome.
Seo JT; Lee JS; Oh TH; Joo KJ
BJU Int; 2007 Jan; 99(1):141-6. PubMed ID: 17092285
[TBL] [Abstract][Full Text] [Related]
10. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
[TBL] [Abstract][Full Text] [Related]
11. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy.
Lanfranco F; Zitzmann M; Simoni M; Nieschlag E
Clin Endocrinol (Oxf); 2004 Apr; 60(4):500-7. PubMed ID: 15049966
[TBL] [Abstract][Full Text] [Related]
12. The effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density.
Dabaja AA; Bryson CF; Schlegel PN; Paduch DA
BJU Int; 2015 Mar; 115(3):480-5. PubMed ID: 25046796
[TBL] [Abstract][Full Text] [Related]
13. Testosterone concentrations in hair of hypogonadal men with and without testosterone replacement therapy.
Thomson S; Koren G; Van Steen V; Rieder M; Van Uum SH
Ther Drug Monit; 2009 Dec; 31(6):779-82. PubMed ID: 19809386
[TBL] [Abstract][Full Text] [Related]
14. Effects of testosterone replacement in hypogonadal men.
Snyder PJ; Peachey H; Berlin JA; Hannoush P; Haddad G; Dlewati A; Santanna J; Loh L; Lenrow DA; Holmes JH; Kapoor SC; Atkinson LE; Strom BL
J Clin Endocrinol Metab; 2000 Aug; 85(8):2670-7. PubMed ID: 10946864
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
16. Effect of testosterone replacement on trabecular architecture in hypogonadal men.
Benito M; Vasilic B; Wehrli FW; Bunker B; Wald M; Gomberg B; Wright AC; Zemel B; Cucchiara A; Snyder PJ
J Bone Miner Res; 2005 Oct; 20(10):1785-91. PubMed ID: 16160736
[TBL] [Abstract][Full Text] [Related]
17. Sex steroids concentrations in relation to bone mineral density in men with coronary atherosclerosis.
Dunajska K; Milewicz A; Jóźków P; Jedrzejuk D; Kuliczkowski W; Lwow F
Maturitas; 2006 Sep; 55(2):142-9. PubMed ID: 16503102
[TBL] [Abstract][Full Text] [Related]
18. Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study).
Shigehara K; Konaka H; Koh E; Nakashima K; Iijima M; Nohara T; Izumi K; Kitagawa Y; Kadono Y; Sugimoto K; Iwamoto T; Mizokami A; Namiki M
Aging Male; 2017 Sep; 20(3):139-145. PubMed ID: 28347184
[TBL] [Abstract][Full Text] [Related]
19. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory.
Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM
J Urol; 2011 Sep; 186(3):1005-11. PubMed ID: 21788049
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
Gonc EN; Kandemir N
Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
